Tango Therapeutics' Series A Round

Tango Therapeutics raised a round of funding on March 30, 2017. Investors include Third Rock Ventures.

Tango Therapeutics is a cancer therapeutics company discovering and developing novel medicines designed to target cancer vulnerabilities beyond mutated oncogenes to deliver transformational new therap…

Articles about Tango Therapeutics' Series A Round: